Telomerase conference coming up (see below). Gern will be presenting there. Wouldn't be surprised to see the media pick up on it.
LARCHMONT, N.Y., May 13 /PRNewswire/ -- Important developments in anti-aging medicine and cancer will be discussed at the Telomeres & Telomerase: Implications for Cell Immortality, Cancer, and Age-Related Disease conference (see liebertpub.com for details and online registration) to be held June 1-3 at the Hotel Sofitel, San Francisco. Organized by BioConferences International, Inc. and sponsored by the Journal of Anti-Aging Medicine published by Mary Ann Liebert, Inc., the conference will explore the remarkable clinical, therapeutic and ethical consequences of telomeres research.
Chaired by Michael Fossel, M.D., Ph.D., Michigan State University and Michael D. West, Ph.D., Origen Therapeutics, the conference will feature the leading experts in the field including Judith Campisi, Ph.D., Berkeley National Laboratory; Calvin B. Harley, Ph.D., Geron Corporation [Nasdaq:GERN - news];
|
